See more : Hemogenyx Pharmaceuticals Plc (HOPHF) Income Statement Analysis – Financial Results
Complete financial analysis of Silence Therapeutics plc (SLN.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Silence Therapeutics plc, a leading company in the Biotechnology industry within the Healthcare sector.
- Mitsubishi Materials Corporation (5711.T) Income Statement Analysis – Financial Results
- PIERER Mobility AG (PKTM.VI) Income Statement Analysis – Financial Results
- Devro plc (DVO.L) Income Statement Analysis – Financial Results
- PT AKR Corporindo Tbk (PKCPY) Income Statement Analysis – Financial Results
- H+H International A/S (0M6J.L) Income Statement Analysis – Financial Results
Silence Therapeutics plc (SLN.L)
About Silence Therapeutics plc
Silence Therapeutics plc focuses on the discovery, development, and delivery of novel RNA therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company designs short interfering RNA (siRNA) molecules that trigger the RNAi pathway and mediate the degradation of specific target messenger RNAs. It is developing various product candidates, including SLN124 for the treatment of iron overload disorders; SLN360 for the cardiovascular disease with high lipoprotein; and SLN500 for the treatment of complement-mediated diseases. Silence Therapeutics plc has a strategic collaboration with AstraZeneca to discover, develop, and commercialize small interfering RNA therapeutics for the treatment of cardiovascular, renal, metabolic, and respiratory diseases; and collaboration with Genomics England Limited. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc is headquartered in London, the United Kingdom.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.48M | 244.00K | 0.00 | 16.00K | 770.00K | 0.00 | 15.00K | 117.00K | 163.00K | 694.00K | 2.37M | 1.72M | 2.21M | 4.05M | 1.95M | 509.00K | 159.00K | 1.00K | 1.15M | 138.00K | 959.00K | 1.37M | 210.00K | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 3.76M | 0.00 | 0.00 | 0.00 | 0.00 | 7.11M | 8.88M | 5.65M | 3.38M | 3.36M | 5.82M | 5.07M | 6.71M | 4.84M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.72M | 244.00K | 0.00 | 16.00K | 770.00K | -7.11M | -8.87M | -5.53M | -3.22M | -2.67M | -3.46M | -3.35M | -4.50M | -796.00K | 1.95M | 509.00K | 159.00K | 1.00K | 1.15M | 138.00K | 959.00K | 1.37M | 210.00K | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 31.34% | 100.00% | 0.00% | 100.00% | 100.00% | 0.00% | -59,126.67% | -4,727.35% | -1,972.39% | -384.29% | -146.03% | -194.43% | -203.85% | -19.67% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 20.21M | 13.34M | 9.74M | 7.94M | 8.71M | 7.11M | 8.88M | 5.65M | 3.38M | 3.36M | 5.82M | 5.07M | 6.71M | 4.84M | 3.19M | 1.66M | 1.70M | 3.01M | 2.46M | 2.49M | 3.00M | 3.05M | 1.68M | 1.83M | 986.00K | 790.00K |
| General & Administrative | 13.98M | 9.64M | 10.83M | 6.46M | 3.97M | 2.66M | 3.26M | 3.54M | 2.61M | 2.65M | 5.13M | 3.19M | 3.29M | 4.99M | 3.03M | 2.75M | 1.83M | 1.01M | 700.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 13.98M | 9.64M | 10.83M | 6.46M | 3.97M | 2.66M | 3.26M | 3.54M | 2.61M | 2.65M | 5.13M | 3.19M | 3.29M | 4.99M | 3.03M | 2.75M | 1.83M | 1.01M | 700.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -269.00K | 7.00K | -112.00K | -20.00K | 72.00K | -154.00K | -21.00K | 56.00K | -1.00K | 1.00K | 0.00 | 673.00K | 693.00K | 503.00K | 429.00K | 329.00K | 258.00K | 143.00K |
| Operating Expenses | 34.19M | 22.98M | 20.57M | 14.41M | 12.68M | 9.77M | 12.14M | 9.19M | 5.72M | 6.01M | 10.84M | 8.25M | 10.07M | 9.68M | 6.19M | 4.46M | 3.53M | 4.02M | 3.16M | 3.17M | 3.69M | 3.55M | 2.11M | 2.16M | 1.24M | 933.00K |
| Cost & Expenses | 37.95M | 22.98M | 20.57M | 14.41M | 12.68M | 16.88M | 21.03M | 14.84M | 9.10M | 9.38M | 16.66M | 13.32M | 16.79M | 14.52M | 6.19M | 4.46M | 3.53M | 4.02M | 3.16M | 3.17M | 3.69M | 3.55M | 2.11M | 2.16M | 1.24M | 933.00K |
| Interest Income | 129.00K | 27.00K | 39.00K | 0.00 | 161.00K | 175.00K | 139.00K | 70.00K | 18.00K | 27.00K | 37.00K | 46.00K | 254.00K | 508.00K | 315.00K | 200.00K | 132.00K | 216.00K | 317.00K | 522.00K | 505.00K | 163.00K | 324.00K | 398.00K | 279.00K | 59.00K |
| Interest Expense | 16.00K | 33.00K | 0.00 | 15.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.00K | 63.00K | 0.00 | 0.00 | 0.00 | 1.00K | 1.00K | 70.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 428.00K | 482.00K | 399.00K | 433.00K | 310.00K | 182.00K | 332.00K | 297.00K | 252.00K | 305.00K | 323.00K | 371.00K | 423.00K | 318.00K | 353.00K | 216.00K | 38.00K | 44.00K | 56.00K | 42.00K | 29.00K | 6.00K | 36.00K | 34.00K | 34.00K | 1.00K |
| EBITDA | -35.60M | -22.36M | -20.13M | -3.33M | -10.05M | -9.25M | -11.65M | -8.71M | -26.03M | -5.42M | -8.41M | -7.14M | -7.01M | -4.93M | -3.59M | -3.42M | -3.20M | -2.41M | -1.65M | -2.51M | -2.20M | -2.01M | -1.54M | -1.73M | -931.00K | -873.00K |
| EBITDA Ratio | -649.70% | -9,161.89% | 0.00% | -20,793.75% | -1,305.45% | 0.00% | -77,653.33% | -7,440.17% | -15,970.55% | -780.84% | -355.41% | -414.22% | -317.43% | -121.72% | -184.18% | -671.51% | -2,011.32% | -241,300.00% | -143.09% | -1,815.94% | -229.51% | -146.72% | -734.76% | 0.00% | 0.00% | 0.00% |
| Operating Income | -36.03M | -22.84M | -20.53M | -3.76M | -10.36M | -9.43M | -11.98M | -9.00M | -26.28M | -5.72M | -8.73M | -7.51M | -7.44M | -5.24M | -3.94M | -3.63M | -3.24M | -2.46M | -1.70M | -2.55M | -2.23M | -2.02M | -1.58M | -1.76M | -965.00K | -874.00K |
| Operating Income Ratio | -657.51% | -9,359.43% | 0.00% | -23,500.00% | -1,345.71% | 0.00% | -79,866.67% | -7,694.02% | -16,125.15% | -824.78% | -369.06% | -435.75% | -336.58% | -129.58% | -202.31% | -713.95% | -2,035.22% | -245,700.00% | -147.96% | -1,846.38% | -232.53% | -147.15% | -751.90% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -16.00K | -33.00K | 0.00 | -15.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -13.00K | -63.00K | 0.00 | 0.00 | 0.00 | -1.00K | -1.00K | -70.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -36.04M | -22.87M | -20.53M | -3.78M | -10.36M | -9.43M | -11.98M | -9.00M | -26.28M | -5.74M | -8.80M | -7.51M | -7.44M | -5.24M | -3.94M | -3.64M | -3.31M | -2.46M | -1.70M | -2.55M | -2.23M | -2.02M | -1.58M | -1.76M | -965.00K | -874.00K |
| Income Before Tax Ratio | -657.80% | -9,372.95% | 0.00% | -23,593.75% | -1,345.71% | 0.00% | -79,866.67% | -7,694.02% | -16,125.15% | -826.66% | -371.72% | -435.75% | -336.58% | -129.58% | -202.36% | -714.15% | -2,079.25% | -245,700.00% | -147.96% | -1,846.38% | -232.53% | -147.15% | -751.90% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -3.49M | -3.29M | -2.12M | -2.16M | -1.92M | -2.78M | -892.00K | 0.00 | 0.00 | 13.00K | 63.00K | -37.00K | 0.00 | -136.00K | -114.00K | -50.00K | -350.00K | -177.00K | -220.00K | -354.00K | -286.00K | 124.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -32.55M | -19.58M | -18.41M | -1.62M | -8.44M | -6.65M | -11.09M | -9.00M | -26.28M | -5.75M | -8.86M | -7.47M | -7.44M | -5.11M | -3.83M | -3.59M | -2.96M | -2.28M | -1.48M | -2.19M | -1.94M | -2.14M | -1.58M | -1.76M | -965.00K | -874.00K |
| Net Income Ratio | -594.03% | -8,025.41% | 0.00% | -10,112.50% | -1,096.10% | 0.00% | -73,920.00% | -7,694.02% | -16,125.15% | -828.53% | -374.39% | -433.60% | -336.58% | -126.22% | -196.51% | -704.32% | -1,859.12% | -228,000.00% | -128.84% | -1,589.86% | -202.71% | -156.20% | -751.90% | 0.00% | 0.00% | 0.00% |
| EPS | -0.40 | -0.26 | -0.26 | -0.02 | -0.12 | -0.10 | -0.22 | -0.20 | -1.37 | -0.58 | -1.41 | -2.47 | -2.76 | -1.95 | -1.79 | -2.62 | -5.50 | -4.25 | -2.76 | -4.09 | -3.78 | -4.62 | -3.51 | -4.01 | -2.22 | -2.33 |
| EPS Diluted | -0.40 | -0.26 | -0.26 | -0.02 | -0.12 | -0.10 | -0.22 | -0.20 | -1.37 | -0.58 | -1.41 | -2.47 | -2.76 | -1.95 | -1.79 | -2.62 | -5.50 | -4.25 | -2.76 | -4.09 | -3.78 | -4.62 | -3.51 | -4.01 | -2.22 | -2.33 |
| Weighted Avg Shares Out | 81.78M | 75.13M | 70.31M | 69.94M | 69.80M | 64.02M | 50.42M | 43.93M | 19.17M | 9.97M | 6.26M | 3.03M | 2.70M | 2.62M | 2.14M | 1.37M | 537.03K | 536.76K | 536.76K | 536.76K | 513.66K | 463.14K | 449.28K | 439.46K | 434.36K | 375.40K |
| Weighted Avg Shares Out (Dil) | 81.78M | 75.13M | 70.31M | 69.94M | 69.80M | 64.02M | 50.42M | 43.93M | 19.17M | 9.97M | 6.26M | 3.03M | 2.70M | 2.62M | 2.14M | 1.37M | 537.03K | 536.76K | 536.76K | 536.76K | 513.66K | 463.14K | 449.28K | 439.46K | 434.36K | 375.40K |
Source: https://incomestatements.info
Category: Stock Reports